Cannabis and alcohol are the two most used substances in the world — but how do they actually interact? A 2026 randomized controlled trial gave participants controlled doses of THC and then measured their alcohol craving and consumption. The results were surprising. Here's the breakdown.

People use cannabis for low mood more than almost any other reason — but what does the science actually show? A 2026 meta-analysis of 123 animal studies gives us the most comprehensive look yet at the biological evidence for CBD and depression. Here's what it means — and what it doesn't.

Between 11% and 17% of Crohn's and colitis patients use cannabis for symptom management. A 2026 systematic review looked at what the science actually shows about THC-containing cannabis and inflammatory bowel disease. The findings are more nuanced than most people realize.

Multiple sclerosis-related muscle spasticity affects most people with MS and is often poorly managed. A 2026 systematic review analyzed 27 randomized trials and over 3,000 patients to find out what cannabis actually does for it. Here's what the strongest evidence yet actually shows.

Jaw pain affects millions of people worldwide and is notoriously hard to treat. A 2026 randomized trial became the first to test oral CBD specifically for this condition. The results weren't what many expected — here's what they actually found and what it means.